PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Core Viewpoint - PacBio will hold a quarterly conference call on February 12, 2026, to discuss its fourth quarter and full year 2025 financial results [1]. Company Overview - PacBio (NASDAQ: PACB) is a leading life science technology company that designs, develops, and manufactures advanced sequencing solutions aimed at resolving genetically complex problems for scientists and clinical researchers [2]. - The company's products and technologies, including HiFi long-read sequencing, cater to a wide range of research applications such as human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications [2]. Conference Call Details - The conference call will take place on Thursday, February 12, 2026, at 5:00 pm Eastern Time (2:00 pm Pacific Time) [2]. - Participants can listen live via the internet or access a replay through PacBio's investor website [2]. - Toll-free and international call-in numbers are provided for participants [2].